Exact Mass: 554.1788
Exact Mass Matches: 554.1788
Found 390 metabolites which its exact mass value is equals to given mass value 554.1788
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Marmesin rutinoside
Marmesin rutinoside is found in herbs and spices. Marmesin rutinoside is a constituent of the roots of Murraya koenigii (curry leaf tree). Constituent of the roots of Murraya koenigii (curry leaf tree). Marmesin rutinoside is found in herbs and spices.
23-Hydroxyphysalolactone
23-Hydroxyphysalolactone is found in fruits. 23-Hydroxyphysalolactone is a constituent of Physalis peruviana (Cape gooseberry) Constituent of Physalis peruviana (Cape gooseberry). 23-Hydroxyphysalolactone is found in fruits.
Lippioside II
Lippioside II is found in herbs and spices. Lippioside II is a constituent of Lippia graveolens (Mexican oregano)
Lappaol C
Lappaol c is a member of the class of compounds known as dibenzylbutyrolactone lignans. Dibenzylbutyrolactone lignans are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. Lappaol c is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lappaol c can be found in burdock, which makes lappaol c a potential biomarker for the consumption of this food product.
Isolappaol C
Isolappaol c is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Isolappaol c can be found in burdock, which makes isolappaol c a potential biomarker for the consumption of this food product.
Arctignan A
Arctignan a is a member of the class of compounds known as dibenzylbutyrolactone lignans. Dibenzylbutyrolactone lignans are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. Arctignan a is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Arctignan a can be found in burdock, which makes arctignan a a potential biomarker for the consumption of this food product.
Lappaol E
Lappaol e is a member of the class of compounds known as dibenzylbutyrolactone lignans. Dibenzylbutyrolactone lignans are lignan compounds containing a 3,4-dibenzyloxolan-2-one moiety. Lappaol e is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lappaol e can be found in burdock, which makes lappaol e a potential biomarker for the consumption of this food product.
7-O-Methylaloeresin A
7-O-Methylaloeresin A is a natural product found in Aloe africana, Aloe perryi, and Aloe marlothii with data available.
8-C-Glucosylchromone 2-O-p-methoxycoumaroyl 5-methyl-7-hydroxy 2-acetonyl
Ligustrosidic acid
Ligustrosidic acid is a natural product found in Ligustrum lucidum and Ligustrum japonicum with data available. Ligustrosidic acid is a natural compound isolated from ligustrum japonicum and ligustrum lucidum[1]. Ligustrosidic acid is a natural compound isolated from ligustrum japonicum and ligustrum lucidum[1].
23-Hydroxyphysalolactone
methyl (4aS,5R,7S,7aS)-7-hydroxy-5-[3-(4-hydroxyphenyl)propanoyloxy]-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate
Guajacylglycerin-beta-pinoresinol-aether|Guajacylglycerin-epipinoresinol-aether
7-O-[beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl]demethylsuberosin
2,3,4,5,6-pentahydroxybenzophenone-(4-O-acetyl-3-O-benzoyl)-O-alpha-L-rhamnopyranoside|petiolin H
6-O-[(6-O-allophanyl)-beta-D-glucopyranosyl]-5-methoxy-7-phenyl-3H-benzo[de]isochromen-1-one
(2S)-2-<2-(6-methoxy)-naphthyl>propyonyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
2,3,4,5,6-pentahydroxybenzophenone-(4-O-acetyl-2-O-benzoyl)-O-alpha-L-rhamnopyranoside|petiolin I
Me glycoside,3-nenzyl,tetra-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose
(7S,8R)-4,7,9,9-tetrahydroxy-3,3-dimethoxy-7-oxo-8-4-oxyneolignan-4-O-beta-D-glucopyranoside|arctiinoside A
6-O-[(6-O-malonyl)-beta-D-glucopyranosyl]-5-methoxy-7-phenyl-3H-benzo[de]isochromen-1-one
4-(O-beta-D-glucopyranosyl)-7,9-dihydroxy-3,3,5-trimethoxy-8,4-oxy-9-norneolignan-7-one
(1S*,2R*,3S*,6S*,7R*,8R*,9S*,10S*,11R*,13Z)-3,9-diacetoxy-6-chloro-8-hydroxy-2-propionyloxybriara-5(16),13-diene-12,18-dione|3, 9-Di-Ac, 2-propanoyl-6-Chloro-2, 3, 8, 9-tetrahydroxy-12-oxo-5(16), 13-briaradien-18, 7-olide
(-)-massoniresinol 4-O-beta-D-glucopyranoside|(-)-massoniresinol 4-O-beta-D-glucopyranoside|(-)-Massoniresinol 4-O-??-D-glucopyranoside
6-methoxysorigenin-8-O-rutinoside|8,9-dihydroxy-6-methoxy-naphthalide 8-O-beta-rutinoside
(3aS,3bR,3cR,4aS,5R,5aR,8aS,8bS,9S,10S,10aR)-3a,3b,3c,4a,5,5a,8a,9,10,10a-decahydro-5,5a-dihydroxy-4a-(hydroxymethyl)-7,9-dimethyl-10a-(1-methylethenyl)-10-(1-oxopropoxy)-2-phenyl-6H-2,8b-epoxyoxireno[6,7]azuleno[5,4-e]-1,3-benzodioxol-6-one|yuanhuaoate A
(-)-(7S,8R,7E)-4,7,9,3,9-pentahydroxy-3,5-dimethoxy-8-4-oxyneolign-7-ene-3-O-beta-D-glucopyranoside
(2S,4S)-7-hydroxy-5,8-dimethoxyflavan-(4->6)-5-hydroxy-7-methoxy-flavanone|sarcandrone D
rel-1beta-(4,6-dihydroxy-2-methoxy)benzoyl-2alpha-(2,6-dimethoxy-4-hydroxy)benzoyl-(3beta,4alpha)-diphenylcyclobutane|rel-1??-(4,6-Dihydroxy-2-methoxy)-benzoyl-rel-2??-(2,6-dimethoxy-4-hydroxy)-benzoyl-rel-(3??,4??)-diphenylcyclobutane
(2S,4S)-7-hydroxy-5,8-dimethoxyflavan-(4->8)-7-hydroxy-5-methoxy-flavanone|sarcandrone C
cleistanthin D
A member of the class of cleistanthins that is cleistanthin A in which the 3,4-di-O-methyl-D-xylopyranosyl group is replaced by a 2,3,4-tri-O-methyl-D-xylofuranosyl group.
C26H34O13_Methyl (4aS,5R,7S,7aS)-1-(beta-D-glucopyranosyloxy)-7-hydroxy-5-{[3-(4-hydroxyphenyl)propanoyl]oxy}-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
methyl (4aS,5R,7S,7aS)-7-hydroxy-5-[3-(4-hydroxyphenyl)propanoyloxy]-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate_major
Cys Asn Arg Tyr
Cys Asn Tyr Arg
Cys Arg Asn Tyr
Cys Arg Tyr Asn
Cys Tyr Asn Arg
Cys Tyr Arg Asn
Asp Glu Glu Tyr
Asp Glu Tyr Glu
Asp Phe His His
Asp His Phe His
Asp His His Phe
Asp Tyr Glu Glu
Glu Asp Glu Tyr
Glu Asp Tyr Glu
Glu Glu Asp Tyr
Glu Glu Phe Met
Glu Glu Met Phe
Glu Glu Tyr Asp
Glu Phe Glu Met
Glu Phe Met Glu
Glu Met Glu Phe
Glu Met Phe Glu
Glu Tyr Asp Glu
Glu Tyr Glu Asp
Phe Asp His His
Phe Glu Glu Met
Phe Glu Met Glu
Phe His Asp His
Phe His His Asp
Phe Met Glu Glu
His Asp Phe His
His Asp His Phe
His Phe Asp His
His Phe His Asp
His His Asp Phe
His His Phe Asp
His His Met Met
His Met His Met
His Met Met His
Met Glu Glu Phe
Met Glu Phe Glu
Met Phe Glu Glu
Met His His Met
Met His Met His
Met Met His His
Met Asn Gln Tyr
Met Asn Tyr Gln
Met Gln Asn Tyr
Met Gln Tyr Asn
Met Tyr Asn Gln
Met Tyr Gln Asn
Asn Cys Arg Tyr
Asn Cys Tyr Arg
Asn Met Gln Tyr
Asn Met Tyr Gln
Asn Gln Met Tyr
Asn Gln Tyr Met
Asn Arg Cys Tyr
Asn Arg Tyr Cys
Asn Tyr Cys Arg
Asn Tyr Met Gln
Asn Tyr Gln Met
Asn Tyr Arg Cys
Gln Met Asn Tyr
Gln Met Tyr Asn
Gln Asn Met Tyr
Gln Asn Tyr Met
Gln Tyr Met Asn
Gln Tyr Asn Met
Arg Cys Asn Tyr
Arg Cys Tyr Asn
Arg Asn Cys Tyr
Arg Asn Tyr Cys
Arg Tyr Cys Asn
Arg Tyr Asn Cys
Tyr Cys Asn Arg
Tyr Cys Arg Asn
Tyr Asp Glu Glu
Tyr Glu Asp Glu
Tyr Glu Glu Asp
Tyr Met Asn Gln
Tyr Met Gln Asn
Tyr Asn Cys Arg
Tyr Asn Met Gln
Tyr Asn Gln Met
Tyr Asn Arg Cys
Tyr Gln Met Asn
Tyr Gln Asn Met
Tyr Arg Cys Asn
Tyr Arg Asn Cys
Lippioside II
Marmesin rutinoside
(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate,4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one
5-O-(4,4-dimethoxytrityl)-2-deoxyinosine
DMT-dI (5'-O-DMT-dI) is a deoxyuridine which can be used in the preparation of convertible nucleoside derivatives[1].
6-Chloro-Benzotriazole-1-yl-oxy-tris-Pyrrolidino-Phosphonium Hexafluorophosphate
4-METHYLPHENYL2,3-BIS-O-(PHENYLMETHYL)-4,6-O-[(R)-PHENYLMETHYLENE]-1-THIO-SS-D-GLUCOPYRANOSIDE
Rolapitant Hydrochloride
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant hydrochloride hydrate (SCH619734 hydrochloride hydrate) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant hydrochloride hydrate does not interact with CYP3A4. Rolapitant hydrochloride hydrate shows potent anti-emetic activity in a ferret emesis model[1][2].
Bedaquiline
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino}-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
(R,S)-Ambrisentan-acyl-beta-D-glucuronide min. 95\\%
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide hydrochloride
Desmethyldescarbamoylnovobiocin(1-)
An organic anion obtained by selective deprotonation of the 4-hydroxy group on the chromene ring of desmethyldescarbamoylnovobiocin.
(4R)-4-[[3-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]-4-hydroxy-5-methoxyphenyl]methyl]-5-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-one
antimycin A9
A benzamide obtained by formal condensation of the carboxy group of 3-formamido-2-hydroxybenzoic acid with the amino group of 3-amino-8-butyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl phenylacetate. It is a microbial metabolite isolated from Streptomyces.
Cudranian 1
A flavonol 7-O-beta-D-glucoside that is kaempferol substituted by a p-hydroxybenzyl group at position 6 and a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It is isolated from the root barks of Cudrania tricuspidata and exhibits radical scavenging effects against 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and anti-lipid peroxidation efficacy on human low-density lipoprotein by TBARS assay.
[(2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone
2-acetamido-6-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-2-deoxy-D-galactopyranose
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-10-(methanesulfonamido)-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
alpha-9-Ac-NeuNAc-(2->6)-GalNAc
An amino disaccharide epitope consisting of an N-acetylglucosamine having an N-acetyl-9-O-acetylneuraminic acid attached via an alpha-(2->6)-linkage
(3r)-4-hydroxy-3-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3h-naphtho[2,3-c]furan-1-one
(2r)-5-hydroxy-6-[(2s,4s)-7-hydroxy-5,8-dimethoxy-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-yl]-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(17r,18r)-18-[(2r)-4-(2,6-dihydroxyphenyl)-4-oxobutan-2-yl]-13,15-dihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
(2s,3r,4r,5r,6r)-2-{3-benzoyl-2,4,6-trihydroxy-5-[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol
9,16,21,22-tetrahydroxy-5,9-bis(hydroxymethyl)-13,20,25-trimethyl-3,23-dioxanonacyclo[14.10.1.0²,⁶.0²,¹⁴.0⁸,¹³.0¹⁰,¹².0¹⁷,¹⁹.0²⁰,²⁷.0²²,²⁶]heptacosa-1(27),5,25-triene-4,24-dione
4-hydroxy-3-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3h-naphtho[2,3-c]furan-1-one
(2s,10r,11r)-10-(3,4-dimethoxyphenyl)-2-hydroxy-4,6-dimethoxy-11-phenyl-9-oxa-14,19-diazapentacyclo[10.7.0.0²,¹⁰.0³,⁸.0¹⁴,¹⁸]nonadeca-1(12),3,5,7,18-pentaen-13-one
(2r)-5-{n-hydroxy-1-[(4s,5r)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]formamido}-2-({hydroxy[(4s,5r)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)pentanoic acid
({[(2s,3r,4r,6r)-16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl](methyl)amino}oxy)methyl acetate
(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl (2s)-2-(6-methoxynaphthalen-2-yl)propanoate
13-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaen-8-yl}-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene
4-(acetyloxy)-7-{[4-(acetyloxy)-6-ethyl-5-methyl-2-oxopyran-3-yl]methyl}-5-(2-methylpropanoyl)-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-6-yl acetate
(1s,2r,4s,5r,7s,8r,11r,12r,13s,14s,15s)-5,15-bis(acetyloxy)-7-chloro-12-hydroxy-1,11,15-trimethyl-6-methylidene-10,16-dioxo-3,9-dioxatetracyclo[12.4.0.0²,⁴.0⁸,¹²]octadec-17-en-13-yl acetate
(2s,3r,4s,5s,6r)-2-(2-{[(1s,2r)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-5-[(1e)-3-hydroxyprop-1-en-1-yl]-3-methoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,5r,6s,9r,10s,11s,15s,16s,17r)-15-(acetyloxy)-6-chloro-9-hydroxy-2,11,15-trimethyl-7-methylidene-3,14-dioxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadec-12-en-17-yl 2-(acetyloxy)acetate
5-hydroxy-8-(3-methylbut-2-en-1-yl)-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-4-one
(3r,4r)-3-[(4-{[(1r,2r)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)methyl]-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
5-hydroxy-8-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-4-one
n-{7-butyl-4,9-dimethyl-2,6-dioxo-8-[(2-phenylacetyl)oxy]-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
(3r,4r)-4-[(4-{[(1r,2r)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3-methoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
7-o-methulaloeresin a
{"Ingredient_id": "HBIN013395","Ingredient_name": "7-o-methulaloeresin a","Alias": "NA","Ingredient_formula": "C29H30O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
Aquilarisinin
{"Ingredient_id": "HBIN016544","Ingredient_name": "Aquilarisinin","Alias": "NA","Ingredient_formula": "C25H30O14","Ingredient_Smile": "CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3=CC(=CC(=C3C(=O)C4=CC=C(C=C4)O)O)O)CO)O)O)O","Ingredient_weight": "554.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32382","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101784424","DrugBank_id": "NA"}
arctignan a
{"Ingredient_id": "HBIN016613","Ingredient_name": "arctignan a","Alias": "NA","Ingredient_formula": "C30H34O10","Ingredient_Smile": "COC1=C(C=CC(=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)OC(CO)C(C4=CC(=C(C=C4)O)OC)O)OC)O","Ingredient_weight": "554.59","OB_score": "NA","CAS_id": "155661-08-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6705","PubChem_id": "73425485","DrugBank_id": "NA"}